NSE · ENNATURE
Ennature Bio Pharma Limited (ENNATURE) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,017
of 5,047 stocks
▼ 1311W
Peak #1,886 · 08 Nov 2026
Ennature Bio Pharma Limited, a microcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and has promoters holding 60%.
Market Cap
443.38 Cr
P/E Ratio
90.62
P/B Ratio
0.83
ROE
0.92%
ROCE
1.11%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 |
|---|---|
| Revenue | 78.46 Cr |
| Net Profit | 4.89 Cr |
| EPS | 2.19 |
| Operating Profit | 6.64 Cr |
Shareholding pattern
Promoter
59.63%
Public
40.37%
Mutual fund holdings
₹6.30
Cr total
5
Schemes
5
Fund Houses
₹6.30 Cr
Total Exposure
WhiteOak Capital Mutual Fund₹3.69 Cr (58.6%)
Motilal Oswal Mutual Fund₹2.59 Cr (41.0%)
Groww Mutual Fund₹0.02 Cr (0.3%)
Mirae Asset Mutual Fund₹0.00 Cr (0.0%)
Bandhan Mutual Fund₹0.00 Cr (0.0%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
No corporate actions on record for this stock.
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.